Robuta

https://theses.gla.ac.uk/84981/ The feasibility of using serious adverse event rates as a measure of trial representativeness for... serious adverse event feasibility using rates measure https://www.birmingham.ac.uk/research/crctu/trials/myechild01/pharmacovigilance-sae-esar-fax-cover-sheet-completion-guidelines Serious Adverse Event related documents - University of Birmingham Serious Adverse Events, SAE, Expected Serious Adverse reaction, eSAR, cover letter, completion guidelines serious adverse event university of birmingham related documents https://www.cgtlive.com/view/sickle-cell-disease-gene-editing-therapy-trial-voluntarily-paused-following-serious-adverse-event Sickle Cell Disease Gene-Editing Therapy Trial Voluntarily Paused Following Serious Adverse Event |... Oct 13, 2026 - The first patient dosed in the study experienced a case of prolonged pancytopenia that has required ongoing transfusion and growth factor support. sickle cell disease serious adverse event gene editing therapy trial